These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7475728)

  • 1. Endometrial changes in patients on tamoxifen.
    Neven P
    Lancet; 1995 Nov; 346(8985):1292. PubMed ID: 7475728
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
    Kuzmanov B
    Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of tamoxifen associated endometrial pathology in breast cancer patients.
    Qureshi A; Bukhari F; Pervez S
    J Pak Med Assoc; 2009 Apr; 59(4):249-50. PubMed ID: 19402291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography.
    Jaeger BM; Grumbach K
    Md Med J; 1997 Sep; 46(8):433-5. PubMed ID: 9294952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of hysteroscopic findings in breast cancer patients having adjuvant tamoxifen treatment.
    Sendag F; Sahin C; Zeybek B; Terek MC; Oztekin K; Bilgin O
    Eur J Gynaecol Oncol; 2010; 31(4):415-7. PubMed ID: 20882884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine side effects of treatment with tamoxifen.
    Andía D; Lafuente P; Matorras R; Usandizaga JM
    Eur J Obstet Gynecol Reprod Biol; 2000 Oct; 92(2):235-40. PubMed ID: 10996688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to the Letter to the Editor on "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by I. Cohen Ann Oncol 2005; 16: 1399.
    Paridaens R; Morales L; Neven P; Timmerman D
    Ann Oncol; 2005 Aug; 16(8):1402-3; author reply 1402-3. PubMed ID: 15870087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tamoxifen and endometrial disease in patients with breast cancer].
    Dalbert DB; Rodríguez de la Peña MM; Figueredo A; Mural J; Bartt O; Subiela R; Rossi C; Bazán G
    Medicina (B Aires); 2013; 73(2):97-103. PubMed ID: 23570756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
    Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen].
    Reslová T; Tosner J; Vávrová I; Resl M
    Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology.
    Morales L; Paridaens R; Timmerman D; Neven P
    Clin Cancer Res; 2006 Sep; 12(18):5603. PubMed ID: 17000698
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD; Aydin Y; Atis A; Mandiraci G
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods.
    Pokharel HP; Bhatla N; Kriplani A; Mukhopadhyay A; Srivastava A; Ralhan R
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):145-51. PubMed ID: 18603889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benign endometrial lesions induced by tamoxifen].
    De Muylder X
    J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):420-4. PubMed ID: 10566160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.
    Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J
    Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of endometrium during tamoxifen therapy of breast cancer].
    Obrebowska A; Sibila-Owczarska A; Sajdak S
    Ginekol Pol; 2002 Nov; 73(11):1109-12. PubMed ID: 12722407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.